Chugai Pharmaceutical

Chugai Pharmaceutical is a Japanese company that develops, manufactures, and sells prescription pharmaceuticals. It focuses on therapeutic areas including oncology, immunology, and bone and joint diseases. The company operates primarily in Japan but also has a global presence through partnerships and licensing agreements.

Why investors watch it

Foreign investors watch Chugai Pharmaceutical as a leading player in Japan's pharmaceutical sector, benefiting from its strong research and development capabilities. It is a subsidiary of Swiss pharmaceutical giant Roche, which enhances its global reach and access to innovative drug pipelines. The stock reflects trends in Japan's healthcare market and global biopharmaceutical developments.